Post-earnings recap
Reported
Tue, Mar 3, 2026
EPS actual
$-2.43
EPS est.
$-0.65
EPS surprise
-274.42%
1-day move
-3.02%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
This earnings report indicates significant challenges for Immunome Inc, particularly with their EPS falling well below expectations. The stock reacted negatively, dropping 3.02% as investors digested the disappointing results. Without any guidance provided, uncertainty remains about the company's future performance and strategy.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-2.43 | N/A | -274.42% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed concerns about the current financial performance. They highlighted the importance of adapting to market conditions.
Management acknowledged the challenges faced this quarter.
They emphasized the need for strategic adjustments moving forward.